Categories
Market & Economy News

Roche’s Gavreto Wins Conditional EU Approval in a Form of Lung Cancer

ZURICH — Roche’s Gavreto has won conditional European Commission approval for treating adults with a form of non-small cell lung cancer, the Swiss drugmaker said on Friday. Read More